Sort   by:  
 Page size 
UnknownIdentifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL.
Not available
S-EPMC10082278 | biostudies-literature
UnknownLong-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.
Not available
S-EPMC4528064 | biostudies-literature
UnknownPI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
Not available
S-EPMC4039496 | biostudies-literature
UnknownProlonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
Not available
S-EPMC8751801 | biostudies-literature
UnknownTargeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
Not available
S-EPMC4513941 | biostudies-literature
UnknownA comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.
Not available
S-EPMC2737286 | biostudies-literature
UnknownLisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Not available
S-EPMC11333271 | biostudies-literature
UnknownGenomic profiling for clinical decision making in lymphoid neoplasms.
Not available
S-EPMC9837456 | biostudies-literature
Sort   by:  
 Page size